Charles N. Serhan

Co-Founder at Resolvyx Pharmaceuticals, Inc.

Charles N. Serhan

Charles N. Serhan

Co-Founder at Resolvyx Pharmaceuticals, Inc.

Biography

Charles N. Serhan, Ph.D.

Dr. Charles N. Serhan is the first Endowed Distinguished Scientist at Brigham and Women's Hospital (BWH) and since 1995 has served as Director of the Center for Experimental Therapeutics and Reperfusion Injury (CET&RI) at BWH. He is a full Professor of Anesthesia at Harvard Medical School, is affiliated with its Department of Biological Chemistry and Molecular Pharmacology, and is also the Simon Gelman Professor of Anesthesia, Perioperative and Pain Medicine (Biochemistry & Molecular Pharmacology) at Harvard Medical School and Professor of Oral Medicine, Infection and Immunity at Harvard School of Dental Medicine. Dr. Serhan is a leading authority in inflammatory resolution and was the first to identify the role of anti-inflammatory cellular mediators such as resolvins and lipoxins in the pro-inflammatory pathway. He serves as the Director and Principal Investigator of the Serhan Laboratory at CET&RI and as the program director of a federally supported National Institutes of Health Program Project grant on the Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology. He is also Principal Investigator on the NIH research grant entitled, Blood Cell Lipoxygenase Products: Formation and Action, funded since 1987, and is honored with a MERIT Award and has authored over 400 papers.

Dr. Serhan received his Bachelor's degree in Biochemistry from Stony Brook University New York and his doctorate in Experimental Pathology and Medical Sciences from New York University School of Medicine. He completed his post-doctoral training in Physiological Chemistry at the Karolinska Institute Medical University in Sweden with Professor Bengt Samuelsson, the 1982 Nobel Laureate in Medicine, and later received an honorary degree from Harvard University.

Overview
Career Highlights

Resolvyx Pharmaceuticals, Inc.

RelSci Relationships

10

Relationships
RelSci Relationships are individuals Charles N. Serhan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Senior Director-Clinical Development at Biogen MA, Inc.

Relationship likelihood: Average

Adjunct Professor of Molecular & Cell Biology at Boston University - Henry M. Goldman School of Dental Medicine

Relationship likelihood: Average

Director at Psychogenics, Inc.

Relationship likelihood: Average

Former President & Chief Executive Officer at XTL Biopharmaceuticals Ltd.

Relationship likelihood: Average

Executive Vice President of Research & Development at Miragen Therapeutics, Inc.

Relationship likelihood: Average

Director at Arvelle Therapeutics GmbH

Relationship likelihood: Weak

Chief Operating Officer at Warp Drive Bio, Inc.

Relationship likelihood: Weak

Vice President, Biology & Preclinical Research & Development at Concert Pharmaceuticals, Inc.

Relationship likelihood: Weak

Vice President of Drug Discovery at Cedilla Therapeutics, Inc.

Relationship likelihood: Weak

President & Chief Executive Officer at Northern Biologics, Inc.

Relationship likelihood: Weak

Paths to Charles N. Serhan
Potential Connections via
Relationship Science
You
Charles N. Serhan
Co-Founder at Resolvyx Pharmaceuticals, Inc.
Career History
Co-Founder
2001 - Prior

Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA.

Investments
Details Hidden

Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA.

Other Affiliations

Charles N. Serhan is affiliated with Resolvyx Pharmaceuticals, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Charles N. Serhan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Charles N. Serhan's profile does not indicate a business or promotional relationship of any kind between RelSci and Charles N. Serhan.